Quantum BioPharma
05/07/2026
Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026
Investigational New Drug (IND) Application Filed to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis
https://www.globenewswire.com/news-release/2026/05/07/3289803/0/en/quantum-reports-strengthened-liquidity-reduced-cash-burn-and-disciplined-cost-management-in-first-quarter-2026.html
$QNTM
Want your practice to be the top-listed Clinic in Toronto?
Click here to claim your Sponsored Listing.
Click here to claim your Sponsored Listing.
Category
Telephone
Address
1 Adelaide Street East Suite 801
Toronto, ON
M5C2V9
